Task: Answer the multiple-choice question.
Question: Which drug exhibits a 0.735% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) COc1ccc(-n2nc3c(c2NC(=O)CCl)CSC3)cc1
b) CCC(C)(C)NC(=O)CN(Cc1cccs1)C(=O)CCC(=O)Nc1nccs1
c) COC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O
Answer: c. COC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O
COC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O
methylN-[1-[(2,6-dichlorophenyl)methyl]-2-oxopyridin-3-yl]carbamate